semaglutide approved Novo Nordisk's weight-loss pill wins FDA approval Oral Semaglutide Approved to Reduce

A double-blinded placebo-controlled phase 2 clinical study in obese patients weekly injections of mazdutide (9 mg) could cause 15.4% decreases in body weight over placebo after 24 weeks

No placebo-treated patients reported suicidal behavior or ideation

If you suspect accidental vein injection, contact your healthcare provider or seek emergency care immediately, especially if symptoms include chest pain, severe shortness of breath, or confusion

It's an easy way to add variety to your morning routine and experiment with natural, whole-food ingredients

Many patients experience a resurgence of hunger cues and food-related thoughts that had been diminished during treatment

Hidradenitis suppurativa: state-of-the-art review and update